Figure S1 from SDP-LIV1, a Novel and Optimized LIV-1 Antibody–Drug Conjugate Demonstrating Superior Antitumor Efficacy and a Favorable Safety Profile for the Treatment of Solid Tumors
Year: 2026
Type: other
Abstract: Figure S1 demonstrates the in vitro stability of SDP-LIV1 in enzyme system and plasma.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7127635678
